Head-to-head · WeighScore
Enhance MD vs TOM Weight Loss
The verdict
Enhance MD takes it — 84.8/100 to 66.3/100.
Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Enhance MD | TOM Weight Loss |
|---|---|---|
| WeighScore | 84.8/100 | 66.3/100 |
| Grade | B | C |
| Site position | #5 | #218 |
| Semaglutide | $249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay | $199/mo (all doses, compounded) |
| Tirzepatide | $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay | $249/mo (all doses, compounded) |
| Coverage | Not publicly listed | 2 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #5 · B
Strengths
- Transparent tiered pricing across sema, tirz, microdose, and combo
- Dose-flat — the price does not step up as you titrate
- Six-month lab testing plus provider-led care
- NAD+ longevity adjacency available
Where it loses points
- Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
- No oral or sublingual route
- States served are not published
- Higher entry price than the cheapest compounded programs
Site position #218 · C
Strengths
- ABOM board-certified physician (Dr. Tran Le, NPI 1194212258, verified ACTIVE)
- Solo-physician model — every patient sees Dr. Le directly
- Flat-rate pricing — no dose escalation surcharge
- LegitScript badge displayed
- No FDA Warning Letters
Where it loses points
- Limited geographic footprint — Texas and Utah only
- No named compounding pharmacy partner disclosed
- Compounded medications are not FDA-approved
- Cash-pay only, no insurance
Featured provider
Enhance MD
Enhance MD scores 84.8/100 (B). A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.